EUREKA PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-06
full format · 31 days before the deadline
22-01
Gazette deed
2 reappointedReappointments: ALMER (director) and LEBO CONSULT (director) · Permanent representatives: Remko Smaak and Wendy Lefebvre · Amendment of the articles21 points ▸
Gazette deed
2 reappointed
Reappointments: ALMER (director) and LEBO CONSULT (director) · Permanent representatives: Remko Smaak and Wendy Lefebvre · Amendment of the articles21 points ▸
- General meeting, 23-12-2025
- Amendment of the articles, mentioned 5 times in the deed
- Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Reserve release, “statutair onbeschikbare eigen vermogensrekening per artikel 39,§2,derde lid, omzetten in beschikbaar eigen vermogen” (deed in Dutch)
- Other provision, “alle huidige inbrengen, boeken inbrengen op onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Other provision, “ontslag voorlezing verslag bestuursorgaan, VIERDE BESLUITa” (deed in Dutch)
- Other provision, “instemming verslag soortvorming, bestuursorgaan” (deed in Dutch)
- Kind of shares, “bijkomende soort creëren, gelijk stemrecht” (deed in Dutch)
- Wendy Lefebvre holds 2,500 shares
- Remko Smaak holds 2,500 shares
- General meeting, “ZESDE BESLUIT, tiende besluit infra” (deed in Dutch)
- Director reappointment, ALMER (director)
- The act holds 9 more points.
2025
30-06
abbreviated format · 31 days before the deadline
2024
01-07
abbreviated format · 30 days before the deadline
2023
31-12
Financial
Liquidity doublescurrent ratio 5.81
The current ratio rises from 2.85 to 5.81. Short-term debt falls from €603,535 to €237,464.
25-08
abbreviated format · 25 days late
2022
23-07
abbreviated format · 8 days before the deadline
2021
31-12
Financial
Highest result from 2018 to 2025net €565,833 ▲231%
The operating result of €785,811 and the net result of €565,833 are both a record.
31-12
Financial
Equity above €1mequity €1.2m ▲93.1%
After 2 profitable years in a row, equity reaches €1.2m.
12-07
abbreviated format · 19 days before the deadline
2020
31-12
Financial
Back to profitnet €171,175
The net result is €171,175, after one loss-making year.
31-12
Financial
Equity above €500,000equity €607,808 ▲39.2%
Equity rises from €436,633 to €607,808.
Show earlier events
07-07
abbreviated format · 24 days before the deadline
2019
31-12
Financial
Weakest financial yearnet -€9,911
The net result drops to -€9,911, the lowest from 2018 to 2025. It recovers the following year.
17-06
abbreviated format · 44 days before the deadline
2018
07-06
abbreviated format · 54 days before the deadline
2017
13-06
abbreviated format · 48 days before the deadline
2005
23-11
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank